tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Riken Vitamin Reports Decline in Q1 FY2025 Profits Amid Overseas Challenges

Story Highlights
  • Riken Vitamin Co., Ltd. saw a decline in sales and profits due to overseas underperformance.
  • Domestic business profits rose by cutting expenses, but overseas sales fell in China and North America.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Riken Vitamin Reports Decline in Q1 FY2025 Profits Amid Overseas Challenges

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Riken Vitamin Co., Ltd. ( (JP:4526) ) just unveiled an announcement.

Riken Vitamin Co., Ltd. reported a decline in consolidated sales and profits for Q1 FY2025, primarily due to underperformance in its overseas business and the impact of yen appreciation. While domestic businesses managed to post higher profits by reducing expenses, the overseas segment faced challenges with declining sales in China and North America. The company’s financial performance was also affected by the absence of gains from the sale of cross-shareholdings and increased personnel and energy costs.

More about Riken Vitamin Co., Ltd.

Riken Vitamin Co., Ltd. operates in the food and chemical industries, focusing on domestic and international markets. The company offers a range of products including household and commercial food items, processed food ingredients, and chemical products.

Average Trading Volume: 50,309

Technical Sentiment Signal: Buy

Current Market Cap: Yen66.29B

For an in-depth examination of 4526 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1